JP2024539138A - 多価効果を持つペプチド - Google Patents

多価効果を持つペプチド Download PDF

Info

Publication number
JP2024539138A
JP2024539138A JP2024523623A JP2024523623A JP2024539138A JP 2024539138 A JP2024539138 A JP 2024539138A JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024539138 A JP2024539138 A JP 2024539138A
Authority
JP
Japan
Prior art keywords
peptide
amino acids
seq
peptides
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539138A5 (cg-RX-API-DMAC7.html
Inventor
シュミッチェン,アルトゥール
ペットラック,ガンナ
Original Assignee
イントゥーキュア エービー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イントゥーキュア エービー filed Critical イントゥーキュア エービー
Publication of JP2024539138A publication Critical patent/JP2024539138A/ja
Publication of JP2024539138A5 publication Critical patent/JP2024539138A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024523623A 2021-10-22 2022-10-21 多価効果を持つペプチド Pending JP2024539138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21204274.1 2021-10-22
EP21204274 2021-10-22
PCT/EP2022/079429 WO2023067167A1 (en) 2021-10-22 2022-10-21 Peptides with multivalent effects

Publications (2)

Publication Number Publication Date
JP2024539138A true JP2024539138A (ja) 2024-10-28
JP2024539138A5 JP2024539138A5 (cg-RX-API-DMAC7.html) 2025-11-11

Family

ID=78592450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523623A Pending JP2024539138A (ja) 2021-10-22 2022-10-21 多価効果を持つペプチド

Country Status (7)

Country Link
US (1) US20250313820A1 (cg-RX-API-DMAC7.html)
EP (1) EP4419664A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024539138A (cg-RX-API-DMAC7.html)
CN (1) CN118202043A (cg-RX-API-DMAC7.html)
AU (1) AU2022369065A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233135A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023067167A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223868A1 (en) * 2023-04-26 2024-10-31 In2Cure Ab Peptides with multivalent effects for topical use
CN121793993A (zh) 2023-09-06 2026-04-03 英图库尔公司 具有抗炎和/或抗微生物特性的材料

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036442A2 (en) * 2009-09-22 2011-03-31 Ximmune Ab Polypeptides and uses thereof
WO2021121843A1 (en) * 2019-12-18 2021-06-24 In2Cure Ab Composition comprising thrombin derived peptides and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009526046A (ja) * 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036442A2 (en) * 2009-09-22 2011-03-31 Ximmune Ab Polypeptides and uses thereof
WO2021121843A1 (en) * 2019-12-18 2021-06-24 In2Cure Ab Composition comprising thrombin derived peptides and use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANTIMICROB. AGENTS CHEMOTHER., vol. 55, no. 6, JPN6026028648, 2011, pages 2880 - 2890, ISSN: 0005908969 *
J. AM. CHEM. SOC., vol. 122, no. 24, JPN6026028649, 2000, pages 5891 - 5892, ISSN: 0005908968 *
NAT. COMMUN., vol. Vol. 9, Article number 2762, JPN6026028646, 2018, pages 1 - 14, ISSN: 0005908970 *

Also Published As

Publication number Publication date
WO2023067167A1 (en) 2023-04-27
US20250313820A1 (en) 2025-10-09
CN118202043A (zh) 2024-06-14
AU2022369065A1 (en) 2024-04-11
EP4419664A1 (en) 2024-08-28
CA3233135A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
CN102655874B (zh) 具有抗炎和抗凝活性的肝素辅因子ii片段
RU2468033C2 (ru) Антибактериальные пептиды
US8735353B2 (en) Polypeptides and uses thereof
KR102499670B1 (ko) 라이신 치환을 포함하는 Romo1 유래 항균 펩타이드 및 그 변이체
US20250313820A1 (en) Peptides with multivalent effects
ES2475765T3 (es) P�ptido antimicrobiano, formas ramificadas del mismo y su uso en el tratamiento de infecciones bacterianas
WO2025208807A1 (zh) 一种抗菌肽Thanatin衍生肽及其医药用途
Kumar et al. Antibacterial, antibiofilm, and anti-inflammatory effects of a novel thrombin-derived peptide in sepsis models: insights into underlying mechanisms
CN115960163A (zh) 抗菌肽、包含抗菌肽的药物组合物及其应用
Shang et al. Engineered peptides harboring cation motifs against multidrug-resistant bacteria
JP4812347B2 (ja) 抗菌性ペプチド
CN112625106A (zh) 一种抗菌多肽化合物、合成方法及其应用
CN108752433B (zh) 抗微生物肽cramp及其环肽在制备清除细菌生物膜的药物中的应用
WO2008104777A2 (en) Peptide
KR20030077950A (ko) 생리활성 복합체
WO2008038777A1 (en) Therapeutic agent for disseminated intravascular coagulation syndrome
GB2500184A (en) Polypeptide derived from helix A of heparin cofactor II
JP2026504224A (ja) ポリペプチドおよびその使用
Cappiello Effects of two L-to D-amino acid substitutions on the structural and functional properties of the antimicrobial peptide esculentin-1a (1-21)
WO2009129164A1 (en) Pharmaceutical combinations of tfpi-fragments and an antibiotic

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251021

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260714